doi:10.1016/j.ophtha.2024.03.004 5
This concern is theoretical for retatrutide specifically, as long-term bone density data are not yet available
Eli Lilly has announced that Phase 3 clinical trials (the TRIUMPH programme ) are underway, investigating retatrutide across a broader population and over longer timeframes
Cyrus Sedaghat can recommend a stepwise plan that may include nutrition targets, activity guidance, and a dosing schedule that is adjusted based on tolerance and results
Discover more tips for managing GLP-1 medication side effects
Common: Nausea, vomiting, diarrhea, or constipation Reduced appetite (sometimes too much) Mild low blood sugar (especially with other diabetes medications) Injection site reactions Less common but serious: Pancreatitis Gallbladder issues Kidney complications from dehydration Thyroid tumors (observed in rodent studies and still under investigation in humans) This is a non-exhaustive list